0001016353-15-000005.txt : 20150505
0001016353-15-000005.hdr.sgml : 20150505
20150505205405
ACCESSION NUMBER: 0001016353-15-000005
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150501
FILED AS OF DATE: 20150505
DATE AS OF CHANGE: 20150505
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACUCELA INC.
CENTRAL INDEX KEY: 0001400482
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 020592619
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1301 SECOND AVE.
STREET 2: SUITE 4200
CITY: SEATTLE
STATE: WA
ZIP: 98101
BUSINESS PHONE: 206-805-8300
MAIL ADDRESS:
STREET 1: 1301 SECOND AVE.
STREET 2: SUITE 4200
CITY: SEATTLE
STATE: WA
ZIP: 98101
FORMER COMPANY:
FORMER CONFORMED NAME: Acucela Inc
DATE OF NAME CHANGE: 20070523
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DANSE EDWARD H
CENTRAL INDEX KEY: 0001016353
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-55133
FILM NUMBER: 15834863
MAIL ADDRESS:
STREET 1: 2525 DUPONT DRIVE
CITY: IRVINE
STATE: CA
ZIP: 92715
4
1
wf-form4_143087363534656.xml
FORM 4
X0306
4
2015-05-01
0
0001400482
ACUCELA INC.
M??????
0001016353
DANSE EDWARD H
C/O ACUCELA INC.
1301 2ND AVE., SUITE 4200
SEATTLE
WA
98101
0
1
0
0
Chief Business Officer
Common Stock
2015-05-01
4
A
0
118369
0
A
118369
D
The issuer's common stock trades on the Tokyo Stock Exchange under the symbol referenced in the issuer's registration statement on Form S-1 (File No. 333-192000).
Mr. Danse was granted 118,369 shares of restricted stock which will be subject to repurchase by the issuer over a four (4) year period if the reporting person's employment is terminated, with 75% of the restricted stock subject to repurchase through 5/1/2016, and the remaining thereafter on a decreasing percentage on a monthly pro rata basis over the following three (3) years, terminating on 5/1/2019.
/s/ John Gebhart as attorney-in-fact for Edward Danse
2015-05-05